Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
peptides
Biotech
Merck links up with Cyprumed in $493M oral peptide deal
Merck will use Cyprumed’s oral peptide delivery platform for an undisclosed number of targets and up to $493 million biobucks on the table.
Zoey Becker
Apr 15, 2025 1:11pm
AbbVie acquires oral peptide biotech Nimble for $200M
Dec 13, 2024 10:38am
GemVax's peptide drug fails phase 2a neurodegenerative trial
Oct 29, 2024 11:28am
MBX aims for $136M IPO to take rival to Ascendis into phase 3
Sep 9, 2024 11:59am
MBX files for IPO to take challenger to Ascendis into phase 3
Aug 26, 2024 9:40am
Baker Lab AI makes strides in drug-like peptides
Apr 25, 2024 2:00pm